Related Experiment Video
Updated: Sep 15, 2025

Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices
Published on: October 29, 2012
Nicotine Disrupts Top-Down Habenular Control Over Cholinergic Inputs to the Ventral Tegmental Area to Increase
Renan C Campos1, Fabio Marti2, Daiana Rigoni1
1Centre National de la Recherche Scientifique, UMR7275, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France; Université Côte d'Azur, Nice, France; Institut National de la Santé et de la Recherche Médicale U1323, Paris, France.
Background:
Tobacco use significantly impacts reward-driven behavior, leading to comorbidities across a lifetime. While the addictive properties of nicotine are well studied, its effects on cellular mechanisms beyond drug-seeking behaviors remain elusive. Here, we investigated the circuit alterations that parallel drug-related behaviors.
Methods:
Male mice were chronically exposed to nicotine in their drinking water for 6 weeks. Then, we combined behavioral measures in operant and non-operant tasks to evaluate changes in motivation while utilizing chemogenetics to selectively modulate cholinergic inputs to the ventral tegmental area (VTA). We combined patch clamp with optogenetics and in vivo electrophysiological recordings to provide a comprehensive cellular analysis of nicotine's impact. Functional assessments were paralleled with high-resolution array tomography to monitor structural adaptations.
Results:
Chronic nicotine dampened the cholinergic modulation of VTA dopamine neuron activity, leading to an exaggerated motivation for food reward seeking. Selective chemogenetic enhancement of cholinergic tone from the laterodorsal tegmentum (LDT) to the VTA restored normal motivational control, while silencing of this projection triggered the opposite effect. We reveal structural and functional deficits in the synaptic integration of excitatory inputs from the lateral habenula (LHb) onto LDT cholinergic neurons projecting to the VTA that correlate with observed behavioral alterations. We identify specific cellular and synaptic changes that underlie nicotine-induced dysregulation of motivation.
Conclusions:
Chronic nicotine consumption alters motivation for natural rewards by disrupting top-down control of the LHb onto the LDT-VTA cholinergic axis. Our work highlights previously unrecognized contributors to nicotine's impact on mental health.
Insights
Chronic nicotine disrupts brain circuits controlling motivation for natural rewards. This study reveals how nicotine alters cellular mechanisms, impacting reward-seeking behaviors and mental health.
Area of Science:
- Neuroscience
- Addiction Research
- Cellular Biology
Background:
- Nicotine addiction profoundly affects reward pathways and behavior.
- Cellular mechanisms underlying nicotine's impact on motivation are not fully understood.
Purpose of the Study:
- Investigate how chronic nicotine exposure alters neural circuits.
- Determine the cellular and synaptic changes associated with nicotine-induced behavioral alterations.
Main Methods:
- Chronic nicotine exposure in male mice.
- Behavioral analysis using operant and non-operant tasks.
- Chemogenetics, patch clamp, in vivo electrophysiology, and array tomography were employed.
Main Results:
- Nicotine exposure reduced cholinergic modulation of ventral tegmental area (VTA) dopamine neurons.
- This led to increased motivation for food reward.
- Structural and functional deficits in the lateral habenula to LDT-VTA pathway were identified.
Conclusions:
- Chronic nicotine disrupts the lateral habenula-LDT-VTA cholinergic pathway, altering motivation for natural rewards.
- This disruption contributes to nicotine's impact on mental health.
More Related Videos
08:07Simultaneous Detection of c-Fos Activation from Mesolimbic and Mesocortical Dopamine Reward Sites Following Naive Sugar and Fat Ingestion in Rats
Published on: August 24, 2016
10:48Probing Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices via Laser Flash Photolysis of Photoactivatable Nicotine
Published on: January 25, 2019
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Cholinergic Receptors: Nicotinic
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
CNS Depressants: Alcohol and Nicotine
Regulation of Food Intake
The Physiology of Taste
Neurochemical Transmission: Sites of Drug Action